Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Giles

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Obstetric Medicine|July 11, 2025
Haemophagocytic lymphohistiocytosis in pregnancy and the postpartum: A case series from the national HLH networkBethan Goulden, Eleanor Singer, Benjamin Bennett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actionsIan Giles, Charis Pericleous, Xiaowei Liu, et al.
Rheumatology (Oxford, England)|June 29, 2022
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprineJohn A Reynolds, Mary Gayed, Munther A Khamashta, et al.
Arthritis and Rheumatism|July 9, 2011
Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasisAnastasia Lambrianides, Tabitha Turner-Stokes, Charis Pericleous, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 7, 2011
Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparinTamara Y Carroll, Melissa J Mulla, Christina S Han, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2025
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodiesHannah F Bradford, Christophe J Lalaurie, Jayesh Gor, et al.
Rheumatology (Oxford, England)|October 3, 2014
Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosisCharis Pericleous, Patricia Ruiz-Limón, Zurina Romay-Penabad, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
Rheumatology (Oxford, England)|April 15, 2024
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren diseaseElizabeth J Price, Stuart Benjamin, Michele Bombardieri, et al.
Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Obstetric Medicine|July 11, 2025
Haemophagocytic lymphohistiocytosis in pregnancy and the postpartum: A case series from the national HLH networkBethan Goulden, Eleanor Singer, Benjamin Bennett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actionsIan Giles, Charis Pericleous, Xiaowei Liu, et al.
Rheumatology (Oxford, England)|June 29, 2022
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprineJohn A Reynolds, Mary Gayed, Munther A Khamashta, et al.
Arthritis and Rheumatism|July 9, 2011
Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasisAnastasia Lambrianides, Tabitha Turner-Stokes, Charis Pericleous, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 7, 2011
Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparinTamara Y Carroll, Melissa J Mulla, Christina S Han, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2025
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodiesHannah F Bradford, Christophe J Lalaurie, Jayesh Gor, et al.
Rheumatology (Oxford, England)|October 3, 2014
Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosisCharis Pericleous, Patricia Ruiz-Limón, Zurina Romay-Penabad, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
Rheumatology (Oxford, England)|April 15, 2024
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren diseaseElizabeth J Price, Stuart Benjamin, Michele Bombardieri, et al.
Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Pageof 8